Resmed (RSMDF) Total Current Liabilities (2010 - 2026)

Resmed (RSMDF) has reported Total Current Liabilities for 17 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 36.89% year-over-year to $1.4 billion; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (up 36.89% YoY), and the FY2026 full-year result was $1.4 billion, up 36.89% from the prior year.
• Total Current Liabilities advanced to $1.4 billion in Q2 2026 per RSMDF's latest filing, from $1.4 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $1.4 billion in Q2 2026 and bottomed at $667.3 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $915.9 million across 5 years, with a median of $812.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities retreated 24.4% in 2022, then surged 46.5% in 2025.
• Over 5 years, Total Current Liabilities stood at $732.7 million in 2022, then grew by 4.28% to $764.1 million in 2023, then climbed by 11.5% to $852.0 million in 2024, then surged by 46.5% to $1.2 billion in 2025, then advanced by 11.78% to $1.4 billion in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.4 billion, $1.4 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.